In order to examine whether SRXN1 was associated with worse prognosis of HCC patients, we investigated the impacts of SRXN1 mRNA expression on OS, RFS, PFS, and DSS among HCC patients from TCGA database using the Kaplan‐Meier plotter. This evidence concerns the gene SRXN1 and hepatocellular carcinoma.